On-Chip Fragment-Based Approach for Discovery of High-Affinity Bivalent Inhibitors

被引：7
|
作者：
Miyazaki, Isao
Simizu, Siro
Ishida, Keisuke
Osada, Hiroyuki [1 ]
机构：
[1] RIKEN, Antibiot Lab, Wako, Saitama 3510198, Japan
来源：
CHEMBIOCHEM | 2009年 / 10卷 / 05期
关键词：
fragment combination array; immobilization; inhibitors; photochemistry; structure-activity relationships; SMALL-MOLECULE MICROARRAYS; CARBONIC-ANHYDRASE-II; LIGAND DISCOVERY; LEAD DISCOVERY; BINDING; LIBRARIES; PRODUCTS; PLATFORM; DESIGN; ARRAYS;
D O I：
10.1002/cbic.200800704
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
[No abstract available]
引用
收藏
页码：838 / 843
页数：6
相关论文
共 50 条
  • [41] Fragment-Based Drug Discovery of Novel MK2 Inhibitors
    Hesterkamp, Thomas
    JOURNAL OF BIOMOLECULAR SCREENING, 2009, 14 (07) : 894 - 895
  • [42] Fragment-Based Discovery of AF9 YEATS Domain Inhibitors
    Liu, Yaqian
    Jin, Ruoxing
    Lu, Hui
    Bian, Kangjie
    Wang, Rui
    Wang, Lei
    Gao, Rui
    Zhang, Jiahai
    Wu, Jihui
    Yao, Xuebiao
    Liu, Xing
    Liu, Dan
    Wang, Xisheng
    Zhang, Zhiyong
    Ruan, Ke
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (07)
  • [43] Electron Density Guided Fragment-Based Lead Discovery of Ketohexokinase Inhibitors
    Gibbs, Alan C.
    Abad, Marta C.
    Zhang, Xuqing
    Tounge, Brett A.
    Lewandowski, Francis A.
    Struble, Geoffrey T.
    Sun, Weimei
    Sui, Zhihua
    Kuo, Lawrence C.
    JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (22) : 7979 - 7991
  • [44] Fragment-Based Discovery of Inhibitors of the Bacterial DnaG-SSB Interaction
    Chilingaryan, Zorik
    Headey, Stephen J.
    Lo, Allen T. Y.
    Xu, Zhi-Qiang
    Otting, Gottfried
    Dixon, Nicholas E.
    Scanlon, Martin J.
    Oakley, Aaron J.
    ANTIBIOTICS-BASEL, 2018, 7 (01): : 1 - 12
  • [45] Fragment-based discovery of potent ERK2 pyrrolopyrazine inhibitors
    Burdick, Daniel J.
    Wang, Shumei
    Heise, Christopher
    Pan, Borlan
    Drummond, Jake
    Yin, JianPing
    Goeser, Lauren
    Magnuson, Steven
    Blaney, Jeff
    Moffat, John
    Wang, Weiru
    Chen, Huifen
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (21) : 4728 - 4732
  • [46] Discovery of Mcl-1 inhibitors using fragment-based methods
    Fesik, Stephen W.
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
  • [47] Fragment-Based Discovery of Indole Inhibitors of Matrix Metalloproteinase-13
    Taylor, Steven J.
    Abeywardane, Asitha
    Liang, Shuang
    Muegge, Ingo
    Padyana, Anil K.
    Xiong, Zhaoming
    Hill-Drzewi, Melissa
    Farmer, Bennett
    Li, Xiang
    Collins, Brandon
    Li, John Xiang
    Heim-Riether, Alexander
    Proudfoot, John
    Zhang, Qiang
    Goldberg, Daniel
    Zuvela-Jelaska, Ljiljana
    Zaher, Hani
    Li, Jun
    Farrow, Neil A.
    JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (23) : 8174 - 8187
  • [48] A Bioinorganic Approach to Fragment-Based Drug Discovery Targeting Metalloenzymes
    Cohen, Seth M.
    ACCOUNTS OF CHEMICAL RESEARCH, 2017, 50 (08) : 2007 - 2016
  • [49] MEDI 243-Discovery of high affinity beta-secretase inhibitors using fragment-based lead generation and structure-based design
    Albert, Jeffrey S.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 234
  • [50] Discovery of Mycobacterium tuberculosis protein tyrosine phosphatase A (MptpA) inhibitors based on natural products and a fragment-based approach
    Manger, M
    Scheck, M
    Prinz, H
    von Kries, JP
    Langer, T
    Saxena, K
    Schwalbe, H
    Fürstner, A
    Rademann, J
    Waldmann, H
    CHEMBIOCHEM, 2005, 6 (10) : 1749 - 1753
12345